The mesenchymal subtype is strongly associated with a higher frequency of neurofibromatosis type 1 (NF1) mutations and upregulation of the tumor necrosis factor (TNF) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). This evidence concerns the gene TNF and neurofibromatosis.